Cargando…
Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile
There are currently no biological tests that differentiate patients with bipolar disorder (BPD) from healthy controls. While there is evidence that peripheral gene expression differences between patients and controls can be utilized as biomarkers for psychiatric illness, it is unclear whether curren...
Autores principales: | Clelland, Catherine L., Read, Laura L., Panek, Laura J., Nadrich, Robert H., Bancroft, Carter, Clelland, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691117/ https://www.ncbi.nlm.nih.gov/pubmed/23826396 http://dx.doi.org/10.1371/journal.pone.0069082 |
Ejemplares similares
-
Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder
por: Clelland, C L, et al.
Publicado: (2016) -
Protecting the world from infectious disease threats: now or never
por: Shahpar, Cyrus, et al.
Publicado: (2019) -
Never say never…
por: Schmidt, Laura A.
Publicado: (2021) -
Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder
por: Versace, Amelia, et al.
Publicado: (2013) -
Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder
por: Calkin, Cynthia, et al.
Publicado: (2021)